We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$6.9B
AUM Growth
-$199M
Cap. Flow
-$157M
Cap. Flow %
-2.27%
Top 10 Hldgs %
24.04%
Holding
3,083
New
373
Increased
407
Reduced
1,584
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 23.96%
2 Healthcare 12.46%
3 Financials 12.39%
4 Consumer Discretionary 12.33%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NLY icon
1951
Annaly Capital Management
NLY
$17.4B
$234K ﹤0.01%
6,949
-279
-4% -$9.6K
QNST icon
1952
QuinStreet
QNST
$1.19B
$234K ﹤0.01%
13,318
+2,334
+21% +$41.9K
INVX
1953
Innovex International
INVX
$2.13B
$233K ﹤0.01%
9,271
CARS icon
1954
Cars.com
CARS
$648M
$233K ﹤0.01%
18,421
+3,354
+22% +$42.4K
NHC icon
1955
National Healthcare
NHC
$3.47B
$232K ﹤0.01%
3,318
-678
-17% -$49.3K
OFIX icon
1956
Orthofix Medical
OFIX
$415M
$232K ﹤0.01%
6,090
MGPI icon
1957
MGP Ingredients
MGPI
$381M
$232K ﹤0.01%
3,562
-747
-17% -$47.9K
RNAM
1958
DELISTED
Avidity Biosciences
RNAM
$231K ﹤0.01%
9,369
CCF
1959
DELISTED
Chase Corporation
CCF
$231K ﹤0.01%
2,258
HSII
1960
DELISTED
Heidrick & Struggles
HSII
$230K ﹤0.01%
5,158
-1,074
-17% -$45.3K
COLL icon
1961
Collegium Pharmaceutical
COLL
$913M
$230K ﹤0.01%
+11,660
New +$252K
VNDA icon
1962
Vanda Pharmaceuticals
VNDA
$314M
$230K ﹤0.01%
13,419
-2,880
-18% -$50.4K
CAL icon
1963
Caleres
CAL
$455M
$230K ﹤0.01%
10,349
WASH icon
1964
Washington Trust Bancorp
WASH
$750M
$230K ﹤0.01%
4,339
-828
-16% -$42.3K
CXW icon
1965
CoreCivic
CXW
$3.32B
$230K ﹤0.01%
25,820
-5,417
-17% -$52.8K
DNOW icon
1966
DNOW Inc
DNOW
$3.04B
$230K ﹤0.01%
30,016
RUBY
1967
DELISTED
Rubius Therapeutics, Inc
RUBY
$229K ﹤0.01%
12,828
VRAY
1968
DELISTED
ViewRay, Inc.
VRAY
$229K ﹤0.01%
31,802
-7,081
-18% -$44.7K
TEN
1969
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$229K ﹤0.01%
16,056
-3,482
-18% -$56.1K
ADPT icon
1970
Adaptive Biotechnologies
ADPT
$3.89B
$229K ﹤0.01%
6,735
-224
-3% -$8.1K
KRNY icon
1971
Kearny Financial
KRNY
$604M
$229K ﹤0.01%
18,398
+2,790
+18% +$34.4K
ACRS icon
1972
Aclaris Therapeutics
ACRS
$860M
$229K ﹤0.01%
12,696
MCHB
1973
Mechanics Bancorp
MCHB
$3.8B
$228K ﹤0.01%
5,552
-1,270
-19% -$49.6K
INSW icon
1974
International Seaways
INSW
$4.58B
$228K ﹤0.01%
+12,518
New +$214K
SP
1975
DELISTED
SP Plus Corporation
SP
$228K ﹤0.01%
7,431

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 Portfolio in Review

As of Q3 2021, Metropolitan Life Insurance Company (MetLife) held 3,083 positions worth $6.9B, down 2.8% from $7.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q3 2021 filing shows 373 new, 407 increased, 1,584 reduced and 241 closed positions. Its largest new stake was Alphabet (Google) Class C: 878,340 shares worth $117M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $17.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2021 buy was Alphabet (Google) Class C: 878,340 shares worth $117M.
  • Metropolitan Life Insurance Company (MetLife) added most to iShares Russell 1000 Growth ETF in Q3 2021, an estimated $17.3M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $17.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $4.87M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $6.9B portfolio in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 373 new positions and closed 241 in Q3 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 2.8% quarter-over-quarter to $6.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2021, filed 15 Nov 2021.